Clinical efficacy of Weisu granule combined with Weifuchun tablet in the treatment of chronic atrophic gastritis and its effect on serum G-17, PG I and PG II levels

Abstract

Objective: The aim of this prospective study was to explore the clinical efficacy of Weisu granules combined with Weifuchun tablets in the treatment of chronic atrophic gastritis and its effect on serum gastrin-17 (G-17), pepsinogen I (PG I), and II (PG II) levels.

Methods: Totally, 120 patients with chronic atrophic gastritis admitted to our hospital from February 2019 to February 2020 were enrolled and randomized into a control group (n=60) treated with Weifuchun tablets, and a experimental group given Weisu granules. Serum G-17, PG I, and PG II levels, inflammatory factor levels, TCM syndrome scores, gastric mucosa pathological scores, and clinical efficacy were compared between the two groups. Gastric tissue changes were observed using gastroscopy and HE staining.

Results: After treatment, the levels of serum G-17, PG I, and PG II of the experimental group were significantly better than those of the control group (P<0.001). The levels of inflammatory factors, traditional Chinese medicine (TCM) syndrome scores, and gastric mucosal pathology scores of the experimental group were significantly lower than those of the control group (P<0.001). The overall response rate of the experimental group was significantly higher than that of the control group (P<0.05). The experimental group showed a lower HP positive result and a higher HP negative conversion ratio than the control group (all P<0.05). HE staining results revealed that after treatment, the number of glands was basically restored to the level of normal gastric mucosa, and the improvement of inflammatory cell infiltration in the experimental group was significantly better than that in the control group.

Conclusion: Weisu granule combined with Weifuchun tablets can ameliorate serum G-17, PG I, and PG II levels in patients with chronic atrophic gastritis, relieve inflammatory responses and clinical symptoms, and improve the treatment effect, which is worth promoting in clinical practice.

Clinical trial registration: Chinese Registry of Clinical Trials.

Trial registration number: ChiCTR200002548416. Trial URL: http://www.chictr.org.cn/showproj.aspx?proj=26516901.

Keywords: Weifuchun tablets; Weisu granules; chronic atrophic gastritis.

Figure 1

Comparison of serum G-17 levels in patients (x̅±sd, ng/L). Note: The horizontal axis indicates before treatment and after treatment, and the vertical axis is serum G-17 level (ng/L). The dotted line represents the experimental group, and the square line represents the control group. *** indicates P<0.001, experimental group vs. control group by two independent sample t-test.

Figure 2

Comparison of serum PG I levels in patients (x̅±sd, μg/L). Note: The horizontal axis from left to right represents before and after treatment, and the vertical axis is serum PG I level (μg/L). The dotted line represents the experimental group, and the square line represents the control group. *** indicates P<0.001, experimental group vs. control group by two independent sample t-test.

Figure 3

Comparison of serum PG II levels in patients (x̅±sd, μg/L). Note: The horizontal axis is from left to right before and after treatment, and the vertical axis is the serum PG II level (μg/L). The black area represents the experimental group, and the gray area represents the control group. *** indicates P<0.001, experimental group vs. control group by two independent sample t-test.

Figure 4

Typical pictures of gastroscopy. Note: (A) Indicated gastroscopy picture of the experimental group before treatment, while (B) Indicated gastroscopy picture of the experimental group after treatment. (C) Indicated gastroscopy picture of the control group before treatment, while (D) Indicated a gastroscopy picture of the control group after treatment. * Mucosa atrophy and submucosal vascular penetration, # The surface of mucous membrane is rough and uneven, and erosion is visible.

Figure 5

Typical pathological pictures of the gastric mucosa (HE stain, Magnified ×100). Note: (A) Indicated a pathological picture of the experimental group before treatment, while (B) Indicated a pathological picture of the experimental group after treatment. (C) Indicated a pathological picture of the control group before treatment, while (D) Indicated a pathological picture of the control group after treatment. The red arrows indicated markedly reduced glands.